复旦学报(医学版)
複旦學報(醫學版)
복단학보(의학판)
FUDAN UNIVERSITY JOURNAL OF MEDICAL SCIENCES
2010年
1期
63-67
,共5页
普罗布考%自微乳化给药系统%星点设计-效应面优化
普囉佈攷%自微乳化給藥繫統%星點設計-效應麵優化
보라포고%자미유화급약계통%성점설계-효응면우화
probucol%self micro-emulsifying drug delivery system%central composite design-response surface methodology
目的 确定普罗布考自微乳化给药系统(self micro-emulsifying drug delivery system,SMEDDS)的较优处方.方法 以微乳粒径、zeta-电位、药物在空白自微乳给药系统的平衡溶解度及5 min时药物的溶出度为指标,采用星点设计-效应面优化法,确定较优处方.结果 处方中橄榄油占油相比例、油相占处方比例及表面活性剂与助表面活性剂的比值分别为0.33、0.5和2.0时,为较优处方.此时微乳粒径为92.7 nm,zeta-电位为-17.38 mV,药物在空白自微乳给药系统中的平衡溶解度为65.17 mg/mL,5 min时药物的溶出度为63.46%.结论 应用星点设计-效应面优化法能够快速方便的得到普罗布考自微乳化给药系统的较优处方,所建立的模型预测性良好.
目的 確定普囉佈攷自微乳化給藥繫統(self micro-emulsifying drug delivery system,SMEDDS)的較優處方.方法 以微乳粒徑、zeta-電位、藥物在空白自微乳給藥繫統的平衡溶解度及5 min時藥物的溶齣度為指標,採用星點設計-效應麵優化法,確定較優處方.結果 處方中橄欖油佔油相比例、油相佔處方比例及錶麵活性劑與助錶麵活性劑的比值分彆為0.33、0.5和2.0時,為較優處方.此時微乳粒徑為92.7 nm,zeta-電位為-17.38 mV,藥物在空白自微乳給藥繫統中的平衡溶解度為65.17 mg/mL,5 min時藥物的溶齣度為63.46%.結論 應用星點設計-效應麵優化法能夠快速方便的得到普囉佈攷自微乳化給藥繫統的較優處方,所建立的模型預測性良好.
목적 학정보라포고자미유화급약계통(self micro-emulsifying drug delivery system,SMEDDS)적교우처방.방법 이미유립경、zeta-전위、약물재공백자미유급약계통적평형용해도급5 min시약물적용출도위지표,채용성점설계-효응면우화법,학정교우처방.결과 처방중감람유점유상비례、유상점처방비례급표면활성제여조표면활성제적비치분별위0.33、0.5화2.0시,위교우처방.차시미유립경위92.7 nm,zeta-전위위-17.38 mV,약물재공백자미유급약계통중적평형용해도위65.17 mg/mL,5 min시약물적용출도위63.46%.결론 응용성점설계-효응면우화법능구쾌속방편적득도보라포고자미유화급약계통적교우처방,소건립적모형예측성량호.
Objective To determine the optimized self micro-emulsifying drug delivery system (SMEDDS) formulation of probucol. Methods According to the indexes of mean particle size, zeta-potential, solubility of probucol in blank SMEDDS and the dissolution percentage in 5 minutes of the preparations, the optimized formulation was determined by the central composite design-response surface methodology. Results When the correspondent percentage of olive oil in oil phase (W/W) was 0.33, the percentage of oil phase in formulation (W/W) was 0.5, and the ratio of surfactant to co-surfactant (W/W) was 2.0, respectively. The mean particle size, zeta-potential, solubility of probucol and dissolution percentage in 5 minutes of micro-emulsion was 92.7 nm, -17.38 mV, 65.17 mg/mL and 63.46%, respectively. Conclusions The optimized formulation of the probucol SMEDDS was obtained quickly and conveniently by the central composite design-response surface methodology. The method had a reliable predictability.